Review




Structured Review

NSABP Foundation sentinel-lymph-node resection
Sentinel Lymph Node Resection, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel-lymph-node+resection/sentinel+lymph+node+resection/pm40482189-240-17-33
Average 90 stars, based on 1 article reviews
sentinel-lymph-node resection - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study.
Article Snippet: Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Article Title: Long-Term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node-Positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy.
Article Snippet: Introduction: In 2018, we reported the results of a study to assess the feasibility of applying the ACOSOG Z0011 criteria to Japanese patients with early-stage breast cancer (median follow-up, 3 years).. Their results over the longer term can now be presented.. Risk factors for axillary and locoregional recurrence in Z0011-eligible patients are unknown.

Article Title: Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea.
Article Snippet: Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillarylymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Article Title: In vivo gene editing of T-cells in lymph nodes for enhanced cancer immunotherapy
Article Snippet: ▪ Krag, David N., et al. "Sentinel-lymph-node resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial."

Article Title: Identification of sentinel lymph node macrometastasis in breast cancer by deep learning based on clinicopathological characteristics
Article Snippet: D Krag, D. N. et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary- lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B32 randomised phase III trial.

Article Title: A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).
Article Snippet: Introduction: Ultrasound is the imaging modality of choice for evaluation of axillary involvement in breast cancer, but is associated with variable sensitivity and specificity.. Understanding the risk of axillary lymph node metastasis (ALNM) based on ultrasonographic and clinical features will inform treatment decisions.. Our group aimed to create a scoring system to quantify the risk of ALNM based on ultrasound characteristics in breast cancer patients.

Article Title: Axillary staging with 18F-FDG PET/CT in early breast cancer: impact of tumor subtypes.
Article Snippet: Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

Article Title: Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
Article Snippet: Krag DN, et al. Sentinel‐lymph‐node resection compared with con‐ ventional axillary‐lymph‐node dissection in clinically node‐negative patients with breast cancer: overall survival findings from the NSABP B‐32 randomised phase 3 trial.



Similar Products

90
NSABP Foundation sentinel-lymph-node resection
Sentinel Lymph Node Resection, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel-lymph-node+resection/sentinel+lymph+node+resection/pm40482189-240-17-33
Average 90 stars, based on 1 article reviews
sentinel-lymph-node resection - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
NSABP Foundation sentinel lymph-node resection
Sentinel Lymph Node Resection, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sentinel-lymph-node+resection/sentinel+lymph+node+resection/pm39455907-211-3-19
Average 90 stars, based on 1 article reviews
sentinel lymph-node resection - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results